We therefore undertook an assessment of the effects of TNFi, IL-6Ri, and JAKi on the levels of both Hb and CRP after 6 months of continuous therapy in adults enrolled in CorEvitas (formerly Corrona), a large US RA registry [25, 26]. Here, GSTM1 is linked to rheumatoid arthritis.